Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Evaluating the Effectiveness of an AI-Powered Physician Assistant in Improving Patients' and Physicians' Satisfaction in Anaesthesiology Clinics

31 de julio de 2026 actualizado por: Dileep Kumar, Aga Khan University

Evaluating the Effectiveness of an AI-Powered Physician Assistant in Improving Patients' and Physicians' Satisfaction in Anaesthesiology Clinics of a Tertiary Care Hospital

This trial aimed to evaluate the effectiveness of an AI-Powered Physician Assistant in improving patients' satisfaction with the quality of care. It also aims to evaluate physicians' satisfaction with the integration of a Physician Assistant into their clinical workflows. The primary research question is

A. What is the effect of an AI-powered Physician Assistant on patients' satisfaction with their quality of care compared to the standard care?

The secondary questions are as follows:

B1. How satisfied are physicians with integrating an AI-powered physician assistant into their daily clinical workflows?

B2. Which factors are significantly associated with patient satisfaction regarding the AI-Powered Physician Assistant?

B3. Is there a statistically significant difference in mean consultation time per patient between those receiving AI-assisted care and those receiving only standard of careonly ?

Participants will be enrolled from pre-operative outpatient clinics, including patients attending clinic for anaesthetic clearance prior to surgery and consultant anaesthetists providing care.

Patients will serve as the unit of randomization and will be assigned to one of two study arms on each clinic day. On each clinic day, the first 8 eligible patients presenting for consultation will be randomly assigned to the intervention group or the control group in a 1:1 ratio. Intervention patients will proceed to a dedicated waiting room for structured digital intake via an AI platform (demographics, symptoms, history, clinical data) and receive AI-assisted care. Control group patients will undergo routine standard care protocols. The consultant physician will evaluate both arms during each clinic session, reviewing physician assistant-generated patient summaries and charts for patients in both the intervention and control groups.

Each patient will be asked to fill out the survey at the end of the consultation with the physician. The consultants will be requested to fill out a survey at the end of the day.

Descripción general del estudio

Tipo de estudio

Intervencionista

Inscripción (Estimado)

180

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Dileep Kumar
  • Número de teléfono: +923332168948
  • Correo electrónico: dileep.kumar@aku.edu

Copia de seguridad de contactos de estudio

Ubicaciones de estudio

    • Sindh
      • Karachi, Sindh, Pakistán, 74800
        • Aga Khan University Hospital
        • Contacto:
        • Contacto:
        • Investigador principal:
          • Dileep Kumar

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

Sí

Descripción

Patients and Patients' Proxies

Inclusion Criteria:

  • Consent to participate
  • Age 18 years and above
  • Initial patients
  • Possession of a phone
  • Read and write Urdu and/or English

Exclusion Criteria:

  • Emergency Care patients
  • Follow-up patients

Physicians:

Inclusion Criteria

  • Attending or Consultant Physician
  • Consent to participate
  • Workflow integrated with AI Assistant

Exclusion Criteria

- Residents and Senior Medical Officers

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Otro
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: AI-Assisted Care
The patients in this arm will receive AI-assisted care in addition to the standard care. The AI platform will take the patient's history, and then the patient will talk to the consultant as part of the routine flow.
The study participant allocated to the intervention arm will interact with the AI-physician assistant application before they consult with the physician. The application will collect medical history of the patient. This will then be followed by an AI-generated clinical summary, which their physicians will receive before the consultation begins. Physicians will review this summary and ask further questions of patients if required. Any additions and changes in the patient's history will also be made. Physicians will subsequently conduct a physical examination of the patient. After this, the physician will be able to view AI- and guideline-based suggestions for the patient's assessment and pre-operative management. The recommendations can be selected, modified, or not used as per the physician's expertise. All additions within the application can be either typed manually or verbalised via an AI-assisted scribe within the application.
Sin intervención: Standard Care
The patients in this arm will receive standard care. The standard of care for our study is what is usually applied in Anaesthesiology outpatient clinics, with consultants seeing the patients after the resident.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Patient Satisfaction and Outpatient Experience Score (Adapted NHS Outpatient Survey - Patient Questionnaire)
Periodo de tiempo: From enrollment to the end of the study, for each patient, for 8 weeks

Patient satisfaction will be evaluated across two domains: (1) effective utilization of waiting time and (2) receipt of patient-centered care during the outpatient visit.

Evaluated post-consultation using a structured survey adapted from the NHS Outpatient Survey: Section A (Wait Time): Wait duration (A1) and wait time utility (A2). Section B (Doctor Interaction): Patient-centered care, consultation duration, listening, and clarity (B2-B7). Section C (AI Assistant - Intervention Arm Only): Perceived listening, trust, and privacy (C1-C6). Section D (Overall Impression): Respect, dignity, and care- quality (D1-D3).

Ordinal items are assigned numerical scores to calculate a composite mean score and domain sub-scores (range: 1.0-5.0). Higher scores indicate greater satisfaction.

From enrollment to the end of the study, for each patient, for 8 weeks

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Daily Physician Satisfaction and Workflow Efficiency Score (End-of-Day Physician Survey)
Periodo de tiempo: From enrollment to the end of the study, for each physician, for 8 weeks

Physician satisfaction and workflow efficiency will be evaluated using an end-of-day survey administered to physicians whose patients were recruited into the study. Evaluated using a two-part structured questionnaire:

Section 1 (Comparative Workflow): Binary comparisons across 5 domains (consultation duration, patient engagement, documentation efficiency, cognitive workload, and focus on patient care), with 3-point follow-up sub-questions for favorable intervention responses.

Section 2 (Intervention Utility): 6 intervention-specific items assessing accuracy/trust, workflow efficiency, workload relief, and overall satisfaction (5-point ordinal scales; 1 = Strongly Disagree, 5 = Strongly Agree).

Daily composite mean scores are calculated from Sections 1 and 2 (range: 1.0-5.0). Higher scores indicate greater satisfaction.

From enrollment to the end of the study, for each physician, for 8 weeks
Total Physician Consultation Duration (Stopwatch Timestamps)
Periodo de tiempo: From enrollment to the end of the study, for each patient, for 8 weeks

Evaluates total physician consultation duration (in minutes) for each patient during their outpatient clinic encounter.

Consultation time refers to the active time spent by the physician while the patient is inside the consultation room. It encompasses the time taken to inquire about symptoms, conduct physical examinations, prescribe treatments, and provide counseling.

Duration is objectively measured in minutes using manual stopwatch timestamps, initiated the moment the patient enters the consultation room and concluded when the patient departs.

Mean total consultation times will be calculated per patient and compared between the intervention and standard care arms. Lower or more optimized consultation durations reflect enhanced workflow efficiency.

From enrollment to the end of the study, for each patient, for 8 weeks

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Process flow evaluation outcome - Mean Queuing Time (Timestamp Tracking)
Periodo de tiempo: From enrollment to the end of the study, for each patient, for 8 weeks

Recorded using objective timestamps across two sequential intervals:

Interval 1: Completion of counter registration to initiation of vital signs measurement.

Interval 2: Completion of vital signs measurement to patient entry into the physician consultation room.

Intervals are combined into a single aggregated total queuing time per patient visit. Lower mean queuing times indicate improved operational workflow efficiency.

From enrollment to the end of the study, for each patient, for 8 weeks

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Investigador principal: Dileep Kumar, Aga Khan University

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

30 de agosto de 2026

Finalización primaria (Estimado)

30 de octubre de 2026

Finalización del estudio (Estimado)

30 de octubre de 2026

Fechas de registro del estudio

Enviado por primera vez

28 de julio de 2026

Primero enviado que cumplió con los criterios de control de calidad

31 de julio de 2026

Publicado por primera vez (Actual)

3 de agosto de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

3 de agosto de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

31 de julio de 2026

Última verificación

1 de julio de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

SÍ

Descripción del plan IPD

The plan is to publish the study, and informed consent has been obtained from each participant. Each participant's data will be de-identified at the source level for both the application and survey.

Criterios de acceso compartido de IPD

Through Publication Only

Tipo de información de apoyo para compartir IPD

  • SAVIA
  • RSC

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir